Patrick Flavin - Aptinyx Sr Relations
| APTXDelisted Stock | USD 0.07 0.01 16.67% |
Insider
Patrick Flavin is Sr Relations of Aptinyx
| Phone | 847 871 0377 |
| Web | https://www.aptinyx.com |
Aptinyx Management Efficiency
The company has return on total asset (ROA) of (0.5135) % which means that it has lost $0.5135 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3806) %, meaning that it created substantial loss on money invested by shareholders. Aptinyx's management efficiency ratios could be used to measure how well Aptinyx manages its routine affairs as well as how well it operates its assets and liabilities.Aptinyx currently holds 22.11 M in liabilities with Debt to Equity (D/E) ratio of 0.39, which is about average as compared to similar companies. Aptinyx has a current ratio of 15.9, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Aptinyx's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Professor MD | Allarity Therapeutics | 67 | |
| Tomasz George | Virax Biolabs Group | 40 | |
| Eugene Jiang | ABVC Biopharma | 38 | |
| Matthew Shatzkes | Aditxt Inc | N/A | |
| Dr IV | Assembly Biosciences | 52 | |
| Alexandra MD | Avenue Therapeutics | 57 | |
| Jason Davis | Virax Biolabs Group | 52 | |
| Laxminarayan Bhat | Reviva Pharmaceuticals Holdings | 59 | |
| Thomas CPA | Aditxt Inc | 51 | |
| W Vernon | Nuvation Bio | 65 | |
| Claus Pedersen | Allarity Therapeutics | 52 | |
| David Hanley | Nuvation Bio | 54 | |
| Karl MD | Achilles Therapeutics PLC | 57 | |
| Jack Reich | Adial Pharmaceuticals | 75 | |
| DPHIL DPhil | CytomX Therapeutics | 57 | |
| Sumita JD | Instil Bio | 50 | |
| Iraj Ali | Achilles Therapeutics PLC | 49 | |
| Ben MD | Neurobo Pharmaceuticals | 68 | |
| James Brady | Spero Therapeutics | N/A | |
| Anna Moore | Transcode Therapeutics | 62 | |
| Oleg Nodelman | Nuvation Bio | 44 | |
Management Performance
| Return On Equity | -1.38 | |||
| Return On Asset | -0.51 |
Aptinyx Leadership Team
Elected by the shareholders, the Aptinyx's board of directors comprises two types of representatives: Aptinyx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aptinyx. The board's role is to monitor Aptinyx's management team and ensure that shareholders' interests are well served. Aptinyx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aptinyx's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kathryn King, VP Operations | ||
| Norbert Riedel, President CEO, Director | ||
| Patrick Flavin, Sr Relations | ||
| Molly Dir, VP HR | ||
| Ashish Khanna, Chief Business Officer | ||
| Harald MD, VP Affairs | ||
| Tim Noffke, VP Staff | ||
| MD BCh, Pres CEO |
Aptinyx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aptinyx a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.38 | |||
| Return On Asset | -0.51 | |||
| Current Valuation | (25.91 M) | |||
| Shares Outstanding | 67.72 M | |||
| Shares Owned By Insiders | 13.12 % | |||
| Shares Owned By Institutions | 42.96 % | |||
| Number Of Shares Shorted | 2.23 M | |||
| Price To Earning | (5.61) X | |||
| Price To Book | 0.33 X | |||
| Price To Sales | 45.33 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Aptinyx Stock
If you are still planning to invest in Aptinyx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptinyx's history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |